超高分辨率HLA分型揭示未识别错配对无关供者造血干细胞移植的影响
该多中心验证研究对5140例常规10/10 HLA匹配的恶性血液病患者进行超高分辨率(UHR)HLA分型,发现82%仍为10/10 UHR匹配,12.3%为12/12 UHR匹配。研究未证实12/12 UHR匹配提高总生存率,但显示UHR匹配者aGVHD风险及特定情况下TRM最低。
要点
- UHR分型可识别常规10/10匹配中未发现的HLA错配,12.3%患者为12/12 UHR匹配。
- UHR错配显著增加2-4级aGVHD风险,HLA-DPB1表位非允许错配风险更高。
- 多个等价年龄10/10供者时,应考虑UHR分型以优选12/12匹配供者。
核心结论
- UHR 12/12 HLA匹配未显著提高总生存率,但aGVHD风险及特定情况下TRM在UHR匹配组最低。
研究设计与样本
- 多中心验证研究,纳入2008-2017年接受无关供者造血干细胞移植的5140例常规10/10 HLA匹配恶性病患者,进行UHR HLA分型。
主要发现
- UHR分型后82%患者仍为10/10 UHR匹配,12.3%为12/12 UHR匹配。
临床怎么用
- 当多个年龄相当的10/10 HLA匹配供者可选时,应考虑UHR HLA分型以优选12/12 UHR匹配供者,降低aGVHD及TRM风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Ultrahigh resolution (UHR) HLA matching is reported to result in better outcomes following unrelated donor hematopoietic cell transplantation, improving survival and reducing post-transplant complications. However, most studies included relatively small numbers of patients. Here we report the findings from a large, multicenter validation study. METHODS: UHR HLA typing was available on 5,140 conventionally 10 out of 10 HLA-matched patients with malignant disease transplanted between 2008 and 2017. RESULTS: After UHR HLA typing, 82% of pairs remained 10 out of 10 UHR-matched; 12.3% of patients were 12 out of 12 UHR HLA-matched. Compared with 12 out of 12 UHR-matched patients, probabilities of grade 2-4 acute graft-versus-host disease (aGVHD) were significantly increased with UHR mismatches (overall P = .0019) and in those patients who were HLA-DPB1 T-cell epitope permissively mismatched or nonpermissively mismatched (overall P = .0011). In the T-cell-depleted subset, the degree of UHR HLA mismatch was only associated with increased transplant-related mortality (TRM) (overall P = .0068). In the T-cell-replete subset, UHR HLA matching was associated with a lower probability of aGVHD (overall P = .0020); 12 out of 12 UHR matching was associated with reduced TRM risk when compared with HLA-DPB1 T-cell epitope permissively mismatched patients, whereas nonpermissive mismatching resulted in a greater risk (overall P = .0003). CONCLUSION: This study did not confirm that UHR 12 out of 12 HLA matching increases the probability of overall survival but does demonstrate that aGVHD risk, and in certain settings TRM, is lowest in UHR HLA-matched pairs and thus warrants consideration when multiple 10 out of 10 HLA-matched donors of equivalent age are available.
引用
- Mayor NP, Wang T, Lee SJ, et al. Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation. J Clin Oncol. 2021. PMID: 33835855. doi:10.1200/JCO.20.03643
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。